Zobrazeno 1 - 10
of 35
pro vyhledávání: '"I. A. Ilovayskaya"'
Autor:
I. A. Ilovayskaya
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 148-152 (2022)
Octreotide is a first-generation somatostatin analog that has been used for 40 years for the medical treatment of acromegaly, both after neurosurgical intervention and as first-line treatment. The frequency of biochemical control against the backgrou
Externí odkaz:
https://doaj.org/article/92cbb8595a584ee78ffa330360524328
Autor:
Y. G. Krivosheeva, I. A. Ilovayskaya
Publikováno v:
Медицинский вестник Юга России, Vol 13, Iss 1, Pp 65-71 (2022)
Purpose: evaluate the fi rst complaints of patients with pituitary macroadenomas, as well as the specialization of doctors, to whom they referred at the fi rst time.Material and methods: data of medical records of 343 patients with pituitary macroade
Externí odkaz:
https://doaj.org/article/9f58b0fec87540df956422fcf67462dd
Autor:
I. A. Ilovayskaya
Publikováno v:
Медицинский совет, Vol 0, Iss 7, Pp 142-149 (2021)
The main goals of treatment for many diseases are to improve the prognosis of diseases and to enhance the quality of life. Among the barriers that restrict achieving these goals we have to mention adherence to treatment. Patients with chronic disease
Externí odkaz:
https://doaj.org/article/9e66828c6d274a3dbe4983b612129ee0
Autor:
A. S. Loktionova, I. A. Ilovayskaya
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 7, Pp 487-493 (2020)
Background: Central hypogonadism (CH) is a syndrome characterized by low levels of peripheral sex steroid hormones due to the lack of central (hypothalamic-pituitary) regulation of reproductive system. In females, CH clinically manifests by amenorrhe
Externí odkaz:
https://doaj.org/article/ce3a9d5faa7c445d871d0e0d89bd62e1
Autor:
A. S. Loktionova, I. A. Ilovayskaya
Publikováno v:
Медицинский вестник Юга России, Vol 10, Iss 4, Pp 15-27 (2019)
Central hypogonadism (CH) is a rare endocrine disorder caused by the disfunction of production, secretion and/or biological action of gonadotropin-releasing hormone (GnRH), which is the main hormonal regulator of hypothalamo-pituitarygonadal axis in
Externí odkaz:
https://doaj.org/article/72ff2111af344924a20ef1f5b04bb504
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 46, Iss 3, Pp 233-239 (2018)
Rationale: International experts emphasize that treatment strategies for patients with acromegaly should be aimed not only at normalization of biochemical parameters, but also at the achievement of better health-related quality of life (HRQL). Howeve
Externí odkaz:
https://doaj.org/article/54995dcb35ac4d3dbea0d0330b136fbc
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 44, Iss 4, Pp 451-456 (2016)
Background: Pituitary adenoma is not as infrequent as thought previously. The prevalence of macroadenomas in general population is up to 0.16–0.2%. Magnetic resonance imaging (MRI) is a method of choice in diagnosis of pituitary adenomas. Until now
Externí odkaz:
https://doaj.org/article/a667d56f02fe441c93146a6d17a22144
Autor:
D. S. Mikhaylova, I. A. Ilovayskaya
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 1, Iss 31, Pp 25-28 (2016)
Background: Premature aging reduces quality of human life, leads to development of “old age diseases” in younger age, and also shortens life expectancy. Aim: Investigation of premature aging markers in women of reproductive age with central untre
Externí odkaz:
https://doaj.org/article/ab88b8a320cd459b9d37f1472eba9cfb
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 32, Pp 31-35 (2016)
Background: Somatostatin analogues therapy is an important part of the acromegalic patients’ treatment. Aim: Assessment of treatment efficiency for patients with acromegaly using different doses of somatostatin analogues. Materials and methods: The
Externí odkaz:
https://doaj.org/article/4eb5ed034ad846fda336988b717bf345
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 32, Pp 97-100 (2016)
Normalization of the growth hormone and IGF-1 levels during somatostatin analogs treatment usually is a predictor of somatotropinoma volume reduction. However, dissociation of biochemical and tumor-supressive effects of somatostatin analogs was also
Externí odkaz:
https://doaj.org/article/9d0b301658d6455cb29100a0c775cb4c